Immunoconjugates

2 trials

Sponsors

Center of Molecular Immunology (CIM)

Conditions

Persistent or relapsing ovary epithelial cancerTumors of head and neck, lung and gliomas

Phase 1

188Re-marked Ior C5 MAb in persistent or relapsing ovary epithelial cancer, phase I.

Active, not recruitingRPCEC00000036

Center of Molecular Immunology (CIM)Persistent or relapsing ovary epithelial cancer

Start: 2008-01-02Target: 15Updated: 2026-03-30

Phase 2

Nimotuzumab cold kit for the immunodiagnosis of solid tumors

Active, not recruitingRPCEC00000290

Center of Molecular Immunology (CIM)Tumors of head and neck, lung and gliomas

Start: 2019-09-30Updated: 2026-03-30